Form 4: NovoCure Executive Uri Weinberg Sells Shares to Cover Tax Obligations
SEC Form 4
Uri Weinberg, Chief Innovation Officer of NovoCure Ltd, sold 268 shares of ordinary stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On March 3, 2025, Uri Weinberg, Chief Innovation Officer of NovoCure Ltd, sold 268 shares of ordinary stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- The shares were sold at a weighted average price of $18.9217, with individual trades ranging from $18.8304 to $18.94.
- Following the transaction, Weinberg directly owns 166,243 shares of NovoCure Ltd.
- The sale was mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.
Sentiment
Score: 5
Explanation: The document describes a routine transaction to cover tax obligations, which is neutral in sentiment.
Industry Context
This is a routine transaction for executives to cover tax obligations related to stock awards. It is common practice and doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the share sale transaction. |
| 03/04/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.